Jeremy G. Reynoso

University of California, Los Angeles

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Willy Hugo

Assistant Professor

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Nicholas Alexander Bayley

University of California, Los Angeles

UNITED STATES

View details

Parmjit Jat

University College London

UNITED KINGDOM

View details

Richard Everson

Assistant Professor In Residence

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Paul Mulholland

Associate Professor

University College London

UNITED KINGDOM

View details

Robert Prins

Professor (with tenure)

Ronald Reagan UCLA Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeremy G. Reynoso

Research Interests

Explore related searches

Contact this professor

Articles (10)

Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells

Clinical Response of Recurrent Ganglioglioma with BRAF A598_T599insV Mutation to BRAF/MEK Inhibitors (P9-6.011)

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma

Abstract B032: Immune landscape of resected brain metastases in patients treated with and without immune checkpoint blockade immunotherapy

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

TMIC-02. PRE-SURGICAL IMMUNE CHECKPOINT BLOCKADE RESHAPES THE IMMUNE LANDSCAPE AND SPATIAL ARCHITECTURE OF METASTATIC BRAIN TUMORS

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

IMMU-41. NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA

Immune Checkpoint Inhibitors Remodel the Immune Microenvironment in Brain Metastases and Promote T Cell Infiltration

Collaborators (6)

Willy Hugo

Nicholas Alexander Bayley

Parmjit Jat

Richard Everson

Paul Mulholland

Robert Prins

Make your next move.